Lopid (Gemfibrozil) 600 mg: Uses, Safety, and Drug Interactions

Lopid is the brand name for gemfibrozil, a prescription lipid-regulating medicine in the fibrate class. It can lower triglycerides and very-low-density lipoprotein cholesterol and may increase high-density lipoprotein cholesterol. It is used in selected patients with certain lipid disorders when diet, weight management, exercise, management of diabetes or thyroid disease, and other risk-reduction measures are not sufficient on their own. Treatment should be individualized after a clinician reviews a fasting lipid profile and the person's cardiovascular, pancreatic, liver, kidney, and medication history.

People considering Lopid should have a valid prescription and a clear reason for treatment. Lopid price depends on the pharmacy, manufacturer, insurance, and prescribed quantity. Cost should not prompt the use of a friend's medicine, a switch from another fibrate, or discontinuation of treatment without speaking with the prescriber. Gemfibrozil is not an emergency treatment for chest pain, stroke symptoms, or severe abdominal pain.

Indications

Gemfibrozil is used for certain forms of hypertriglyceridemia and dyslipidemia. Very high triglycerides can increase the risk of pancreatitis, and treatment may be part of a plan to reduce that risk in selected patients. It is not a substitute for dietary changes or management of conditions that can raise triglycerides, such as uncontrolled diabetes, alcohol use, hypothyroidism, kidney disease, and some medicines. The clinician should assess and address these contributors.

Lipid treatment should be based on a complete risk assessment rather than a single cholesterol value. Regular follow-up may include fasting lipids, liver tests, kidney assessment, and review of diet, alcohol intake, weight, blood glucose, and other cardiovascular risk factors. New severe upper abdominal pain with nausea or vomiting can signal pancreatitis or gallbladder disease and needs urgent medical evaluation.

Dosage

The usual prescribed Lopid regimen is 600 mg twice daily, generally taken 30 minutes before the morning and evening meals. The prescriber determines whether this medicine is appropriate and how long treatment should continue. Patients with a valid prescription can buy Lopid 600 mg when it matches the current prescription. Take the tablets exactly as directed and continue the diet and activity plan provided by the care team.

Do not change the dose based on a home cholesterol result or because you feel well. Lipid levels may take time to respond, and the clinician may reassess treatment after repeat laboratory testing. If a dose is missed, follow the pharmacy label or contact a pharmacist; do not take two doses together. Patients should buy Lopid only from a licensed pharmacy that provides the prescribed medicine and access to dispensing advice.

Lopid price should be discussed with the pharmacist, insurer, or prescriber before it leads to skipped doses. Do not replace gemfibrozil with fenofibrate or a statin without a clinician's direction, because these medicines have different indications, interaction profiles, and monitoring requirements. Patients with kidney or liver impairment may need a different approach, and self-adjustment can increase harm.

Safety Information

Lopid is contraindicated in people with hepatic dysfunction, severe kidney dysfunction, preexisting gallbladder disease, hypersensitivity to gemfibrozil, or concurrent repaglinide use. It should not be combined with simvastatin, and combinations with other statins can substantially increase the risk of serious muscle injury. Tell the prescriber about all prior liver, kidney, gallbladder, muscle, thyroid, or diabetes problems before treatment begins.

Gemfibrozil can increase the risk of myopathy and rhabdomyolysis, a serious breakdown of muscle that can damage the kidneys. Seek prompt medical care for unexplained muscle pain, tenderness, weakness, dark or cola-colored urine, marked fatigue, fever, or reduced urination, especially if you also take a statin. Gallstones and gallbladder disease can occur. Contact the clinician for severe or persistent upper abdominal pain, pain after meals, nausea, vomiting, fever, or jaundice.

Other possible effects include indigestion, abdominal pain, diarrhea, nausea, rash, headache, fatigue, dizziness, and changes in liver tests or blood counts. Report yellowing of the skin or eyes, dark urine, pale stools, unusual bruising, visual changes, or persistent symptoms. Avoid excess alcohol because it can raise triglycerides and add to liver risk. The decision to buy Lopid must remain part of a clinician-monitored treatment plan, including repeat laboratory work.

Interactions

Gemfibrozil has important drug interactions. It is contraindicated with repaglinide because it can markedly raise repaglinide exposure and the risk of severe low blood sugar. It can increase the effect of warfarin and other anticoagulants, so bleeding monitoring and dose adjustment may be necessary. Tell the prescriber about bruising, black stools, nosebleeds that are hard to stop, or any other unusual bleeding.

Do not combine Lopid with simvastatin. Other statins may also increase the risk of myopathy or rhabdomyolysis when used with gemfibrozil, so the prescriber must determine whether any combination is justified and how it will be monitored. Bile-acid sequestrants such as cholestyramine or colestipol can reduce gemfibrozil absorption; pharmacists can advise on the appropriate timing. Gemfibrozil may also affect other medicines processed by certain liver enzymes.

Give every clinician and pharmacist a current list of prescription medicines, nonprescription products, vitamins, herbal remedies, and supplements. Lopid price should not take priority over interaction screening, appropriate lab monitoring, or a safe source. A valid prescription is required to buy Lopid, and treatment changes should be directed by the prescriber.

Medical disclaimer: This content is for informational purposes only and does not replace advice, diagnosis, or treatment from a licensed healthcare professional. It is not a substitute for approved prescribing information or emergency care. Patients should follow their prescriber's directions and consult their healthcare professional about personal medical decisions, symptoms, medicines, monitoring, and treatment changes.